Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis

Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis

Bibliographic Details
Main Authors:	J Kanis, M Stevenson, E McCloskey, S Davis, M Lloyd-Jones
Format:	Article
Language:	English
Published:	NIHR Journals Library 2007-03-01
Series:	Health Technology Assessment
Online Access:	https://doi.org/10.3310/hta11070

Similar Items

Treatment of established osteoporosis: a systematic review and cost-utility analysis
by: J.A. Kanis, et al.
Published: (2002-01-01)

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis.
by: Lekamwasam, S, et al.
Published: (2012)

Management of glucocorticoid-induced osteoporosis.
by: Rizzoli, R, et al.
Published: (2012)

An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis
by: Lekamwasam, S, et al.
Published: (2012)

An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis.
by: Lekamwasam, S, et al.
Published: (2012)

Glucocorticoid-induced osteoporosis
by: I. S. Dydykina, et al.
Published: (2005-02-01)

Glucocorticoid-induced osteoporosis
by: Kripa Elizabeth Cherian, et al.
Published: (2017-01-01)

Ukrainian frax: criteria for diagnostics and treatment of osteoporosis
by: V. Povoroznyuk, et al.
Published: (2019-10-01)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
by: Kanis, J, et al.
Published: (2013)

Development and validation of a disease model for postmenopausal osteoporosis.
by: Gauthier, A, et al.
Published: (2011)

Denosumab in the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
by: Yanbeiy ZA, et al.
Published: (2019-08-01)

Epidemiology of glucocorticoid-induced osteoporosis.
by: Dennison, E, et al.
Published: (2002)

Update on Glucocorticoid Induced Osteoporosis
by: Soo-Kyung Cho, et al.
Published: (2021-06-01)

Glucocorticoid-induced osteoporosis: 2013 update
by: M. Mazzantini, et al.
Published: (2014-07-01)

DEVELOPMENT AND VALIDATION OF AN EPIDEMIOLOGICAL MODEL TO ESTIMATE THE BURDEN OF POST-MENOPAUSAL OSTEOPOROSIS
by: Gauthier, A, et al.
Published: (2010)

Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).
by: Ström, O, et al.
Published: (2011)

Glucocorticoid-induced osteoporosis: pathogenesis and prevention
by: I. G. Krasivina, et al.
Published: (2020-01-01)

Zebrafish models for glucocorticoid-induced osteoporosis
by: Wen-Ying Lin, et al.
Published: (2022-01-01)

Update on the Treatment of Glucocorticoid-Induced Osteoporosis
by: Ai Lee Lim, et al.
Published: (2022-06-01)

Glucocorticoid-induced osteoporosis in rheumatic diseases
by: Rosa Maria Rodrigues Pereira, et al.
Published: (2010-01-01)

Linking glucocorticoid-induced osteoporosis to osteoimmunology
by: Stephan von Gunten, et al.
Published: (2020-12-01)

Animal Model for Glucocorticoid Induced Osteoporosis: A Systematic Review from 2011 to 2021
by: Andy Xavier, et al.
Published: (2021-12-01)

Glucocorticoids induce osteoporosis mediated by glucocorticoid receptor-dependent and -independent pathways
by: Yu Jiang
Published: (2020-10-01)

Glucocorticoid-induced osteoporosis: lessons from Cushing's syndrome.
by: Tóth, M, et al.
Published: (2013)

GLUCOCORTICOID-INDUCED OSTEOPOROSIS: DIAGNOSIS, PREVENTION, AND TREATMENT
by: N. V. Toroptsova
Published: (2014-09-01)

GLUCOCORTICOID-INDUCED OSTEOPOROSIS: PATHOGENESIS, PREVENTION, TREATMENT
by: Irina Aleksandrovna Baranova
Published: (2010-06-01)

New possibilities for the treatment of glucocorticoid-induced osteoporosis
by: I.A. Baranova
Published: (2014-05-01)

Glucocorticoid-Induced Osteoporosis: The Potential Role of Romosozumab
by: Jacqueline So, et al.
Published: (2020-12-01)

Role of teriparatide in treatment of glucocorticoid-induced osteoporosis
by: Arthur N Lau, et al.
Published: (2010-10-01)

The molecular etiology and treatment of glucocorticoid-induced osteoporosis
by: Cheng-Huan Peng, et al.
Published: (2021-01-01)

The critical role of T cells in glucocorticoid-induced osteoporosis
by: Lin Song, et al.
Published: (2020-12-01)

Burden of postmenopausal osteoporosis in Germany: estimations from a disease model.
by: Gauthier, A, et al.
Published: (2012)

Burden of postmenopausal osteoporosis in Germany: estimations from a disease model
by: Gauthier, A, et al.
Published: (2012)

Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
by: Lianghai Jiang, et al.
Published: (2022-11-01)

A systematic review of hip fracture incidence and probability of fracture worldwide.
by: Kanis, J, et al.
Published: (2012)

Osteoporosis inducidapor glucocorticoides
by: Maria Lorena Brance, et al.
Published: (2014-09-01)

Development and validation of a disease model for postmenopausal osteoporosis.
by: Gauthier, A, et al.
Published: (2011)

Epidemiological burden of postmenopausal osteoporosis in the UK from 2010 to 2021: estimations from a disease model.
by: Gauthier, A, et al.
Published: (2011)

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis
by: M Stevenson, et al.
Published: (2005-06-01)

A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update.
by: Eastell, R, et al.
Published: (1998)